Clinical Trial

Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.

Study acronym: STARS extend
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The primary objective of the trial is to assess long-term safety and tolerability of apraglutide in subjects with SBS-IF.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2021-08-17; most recent amendment 2025-07-01.
Status change: Recruiting → Active, Not Recruiting 2024-01-08
Trial Details
NCT Number NCT05018286
Lead Sponsor VectivBio AG
Conditions Short Bowel Syndrome
Enrollment 158 participants
Start Date 2021-07-13
Primary Completion 2027-10-30 (estimated)
Study Completion 2027-10-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-02